Drug and pharmaceutical recalls
354 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
Recent recalls
Page 7 of 12- PReye Vitamin See eye drops recalled for sterility concerns
PReye LLC is recalling all lots of PReye Vitamin See Antioxidant Preservative Free Eye Drops due to lack of assurance of sterility. The recall affects approximately 50 to 60 bottles distributed in Colorado. No injuries have been reported.
ModerateFDAJul 1, 2026PReye
- ANI Pharmaceuticals hydroxyzine solution recalled for foreign substance
ANI Pharmaceuticals is recalling hydroxyzine hydrochloride oral solution (10 mg/5 mL, 473 mL bottles) due to the presence of a foreign substance in one lot. The affected product was distributed nationwide. No injuries have been reported.
ModerateFDAJul 1, 2026ANI Pharmaceuticals
- Central Admixture pediatric TPN bag missing required nutrients
Central Admixture Pharmacy Services issued a recall for one patient-specific Total Parenteral Nutrition (TPN) bag that did not contain copper and famotidine as listed on the label. The bag was prepared for a pediatric patient in Massachusetts. No injuries have been reported.
ModerateFDAJul 1, 2026Central Admixture Pharmacy Services
- Direct Rx Duloxetine D/R recalled for impurity risk
Direct Rx's packaged Duloxetine D/R 30 mg capsules contain levels of N-nitroso-duloxetine, a potentially harmful impurity, above FDA's recommended limit. This is a manufacturing quality issue affecting specific lots distributed nationwide.
ModerateFDAJul 1, 2026Direct Rx
- Amgen Corlanor and Sensipar tablets recalled for foreign substance
Amgen is recalling five bottle sizes of two prescription heart and thyroid-related drugs, Corlanor (ivabradine) and Sensipar (cinacalcet), because the tablets may contain a foreign substance. The products were distributed nationwide, and no injuries have been reported.
ModerateFDAJul 1, 2026Amgen5 products
- Ajanta Pharma fenofibrate capsules recalled for CGMP deviations
Ajanta Pharma USA Inc. is recalling one lot of fenofibrate 200 mg capsules due to manufacturing quality deviations discovered during inspection. The affected lot (PA02216, expiring 12/2029) was distributed nationwide.
ModerateFDAJul 1, 2026Ajanta Pharma
- Major Pharmaceuticals Methylergonovine Maleate recalled for subpotency
MAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.
ModerateFDAJul 1, 2026The Harvard Drug
- Med Pride, Lucky and more creams recalled for quality issues
Dabur is recalling 14 antibiotic and antifungal creams, ointments and first aid products, including Lucky Super Soft, Circle K, Lil Drug Store, Rapidol, Cura Hongos and Med Pride. The FDA found manufacturing quality problems (CGMP deviations) during an inspection. No injuries have been reported.
ModerateFDAJun 24, 2026Dabur14 products
- Inventia chlorthalidone tablets recalled for failed dissolution
Inventia Healthcare Limited's chlorthalidone 25 mg tablets failed to meet dissolution specifications, meaning the tablets may not break down properly in the body and deliver the full dose. This affects 100-tablet and 1000-tablet bottles distributed nationwide. No injuries have been reported.
ModerateFDAJun 24, 2026Inventia Healthcare
- Sandoz Focalin XR recalled for missing expiration date
Sandoz is recalling one lot of Focalin XR (dexmethylphenidate HCl) 5 mg extended-release capsules because some bottles have incorrect or missing lot numbers and expiration dates on the label. The affected lot (VA0099422) was distributed nationwide. This is a labeling issue only; the medication itself has not been found to be unsafe.
FDAJun 24, 2026Sandoz
- Pearson, Quala and more benzocaine gels recalled for incomplete seals
Keystone Industries is recalling 7 topical anesthetic gels containing 20% benzocaine, sold as Pearson Quality, Quala, DHP, Burkhart, Dental City, PureLife, and safco SensiCaine-Ultra. The recall is due to a container defect: some bottles may have incomplete seals. No injuries have been reported.
ModerateFDAJun 24, 2026Keystone Industries7 products
- Par Health USA buprenorphine injection recalled for crystallization
Par Health USA's buprenorphine HCl injection (0.3 mg/mL) has been found to contain crystallization identified as buprenorphine free base in certain lots. This affects vials distributed nationwide. The FDA has classified this as a Class II recall.
ModerateFDAJun 24, 2026Paragon 28
- Ajanta aripiprazole tablets recalled for voriconazole mix-up
Ajanta Pharma USA Inc. distributed bottles labeled as Aripiprazole 30 mg that actually contained Voriconazole 50 mg, a different medication used to treat fungal infections. This mix-up affected 6,143 bottles (Lot PA00805, expiring 01/31/2029) distributed nationwide. The error was discovered and reported to the FDA.
SeriousFDAJun 24, 2026Ajanta Pharma
- IntegraDose Vasopressin syringes recalled for subpotency
IntegraDose Compounding Services LLC is recalling Vasopressin 2 Units/2 mL syringes because the drug may contain less active ingredient than labeled. This affects two specific lots distributed nationwide. No injuries have been reported.
ModerateFDAJun 24, 2026IntegraDose
- Kerr Insta-Char charcoal recalled for not meeting OTC standards
VistaPharm is recalling four sizes of Kerr Insta-Char activated charcoal with cherry flavor, in aqueous and sorbitol bases. The product did not meet the FDA over-the-counter monograph M023 standard. No injuries have been reported.
ModerateFDAJun 24, 2026Pain Train Salsa4 products
- Glenmark Alyacen 7/7/7 tablets recalled for impurity levels
Glenmark Pharmaceuticals is recalling specific lots of Alyacen 7/7/7 (a birth control pill) because testing found higher-than-allowed impurity levels in the tablets. The affected lots were distributed nationwide. No injuries have been reported.
ModerateFDAJun 24, 2026Glenmark
- Sun Pharmaceutical budesonide inhalation suspension recalled for foreign particles
Sun Pharmaceutical has recalled budesonide inhalation suspension (1mg/2mL single-dose ampules) due to the presence of black or brown specs and particles found in some vials. The affected lot is BAG0074A with an expiration date of January 31, 2027. This is a quality issue that could affect the safety and sterility of the medication.
ModerateFDAJun 17, 2026Sun Pharmaceutical
- Ascend minocycline tablets recalled for failed dissolution test
Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets, 115 mg (lot 25141635, expires 4/30/2028) because testing found the tablets did not dissolve properly as required. This affects 360 bottles distributed nationwide. No injuries have been reported.
ModerateFDAJun 17, 2026Ascend Laboratories
- Gas-X Extra Strength SoftGels recalled for coolant contamination
Gas-X Extra Strength softgels were contaminated with a diluted propylene glycol-based coolant during packaging due to a machine leak. The contamination affected specific lot numbers distributed nationwide. No injuries have been reported.
SeriousFDAJun 17, 2026Haleon
- Golden State Medical Supply niacin tablets recalled for dissolution failure
Golden State Medical Supply is recalling specific lots of niacin extended-release tablets (1,000 mg) because they failed to dissolve properly during stability testing. The tablets did not meet dissolution specifications at the 24-hour mark, which means they may not release the medication as intended in the body.
ModerateFDAJun 17, 2026Golden State Medical Supply
- Zep Alcohol Sanitizer Spray recalled for microbial contamination
Zep Inc. is recalling Alcohol Sanitizer Spray (Ethanol 70%, 55-gallon drums) due to microbial contamination. The affected batch (E2612116, expiration April 2029) was distributed nationwide. A total of 5 drums are involved.
ModerateFDAJun 17, 2026Zep
- Amneal primidone tablets recalled for possible cross-contamination
Amneal Pharmaceuticals is recalling Primidone 50 mg tablets (NDC 53746-544-01, lot AM251676) due to potential cross-contamination with Acemetacin during manufacturing at the API supplier. The contamination could affect the safety or effectiveness of the medication.
ModerateFDAJun 17, 2026Amneal Pharmaceuticals
- Breckenridge duloxetine capsules recalled for nitrosamine impurity
Breckenridge is recalling two sizes of duloxetine delayed-release capsules, 30 mg and 60 mg, made by Towa Pharmaceutical Europe in Spain. The recall covers about 374,400 bottles distributed nationwide. The capsules contain an impurity called N-nitroso-duloxetine at a level above the FDA's recommended interim limit. No injuries have been reported.
ModerateFDAJun 17, 2026Breckenridge2 products
- Fresenius Kabi epinephrine injection recalled for impurity concerns
Fresenius Kabi USA is recalling specific batches of epinephrine injection due to failed impurity and degradation specifications. The affected vials may not meet required purity standards. No injuries have been reported.
ModerateFDAJun 17, 2026Fresenius Kabi
- Sun Pharmaceutical doxorubicin injection recalled for glass particles
Sun Pharmaceutical's doxorubicin hydrochloride liposome injection vials were found to contain glass particles. The affected vials are lot HAG2581B, which expire in May 2027. About 675 vials were distributed nationwide.
SeriousFDAJun 17, 2026Sun Pharmaceutical
- Beekeeper's Naturals nasal spray recalled for microbial contamination
Beekeeper's Naturals Saline Nasal Spray was manufactured without proper sterilization, allowing microbial contamination. The affected product is Lot #5950 with an expiration date of 02/2028. No injuries have been reported so far.
ModerateFDAJun 17, 2026Beekeeper's Naturals
Beekeeper's Naturals saline nasal spray recalled for possible Aspergillus contaminationBeekeeper's Naturals is recalling one lot of its Saline Nasal Spray sold on Amazon because it contains elevated levels of yeast and may be contaminated with Aspergillus, a fungus that can cause serious infections in people with weakened immune systems or lung disease. The company has received four reports of sinus congestion, irritation, or infection potentially linked to this product.
SeriousFDAJun 11, 2026Beekeeper's Naturals
- BD ChloraPrep and FREPP applicators recalled for fungal contamination
BD is recalling specific lots of ChloraPrep Clear 1 mL and FREPP Clear 1.5 mL skin preparation applicators due to potential fungal contamination (Aspergillus penicillioides) that could grow under certain environmental conditions. The affected products were distributed to hospitals and medical distributors between March and June 2024.
SeriousFDAJun 6, 2026BD
- PRED MILD eye drops recalled for failed stability specifications
AbbVie is recalling specific lots of PRED MILD (prednisolone acetate) eye drops because they failed stability testing. The affected product may not maintain its intended strength or safety over time. Two lots are involved, with an expiration date of August 2026.
ModerateFDAJun 3, 2026AbbVie
- Aveva nicotine patches recalled for failed impurity specifications
AVEVA nicotine patches (14 mg) distributed by Rugby Laboratories have elevated levels of chemical impurities that exceed safety standards for shelf life. The issue was discovered during stability testing of specific lots. No injuries have been reported.
ModerateFDAJun 3, 2026AVEVA